Description

Votrient (Pazopanib): Uses, Benefits, and Important Safety Information

What is Votrient?

Votrient is the brand name for pazopanib, an oral targeted therapy used to treat certain types of cancer. It belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs), which work by blocking proteins involved in tumor growth and blood vessel formation.

Indications

Votrient is approved for the treatment of:

• Advanced renal cell carcinoma (RCC), a type of kidney cancer.
• Advanced soft tissue sarcoma (STS) in adults who have previously received chemotherapy.

Treatment should be initiated and monitored by healthcare professionals experienced in cancer therapy.

How Votrient Works

Pazopanib inhibits multiple tyrosine kinase receptors, including vascular endothelial growth factor receptors (VEGFRs) and platelet-derived growth factor receptors (PDGFRs). By blocking these pathways, Votrient helps reduce the blood supply to tumors and may slow cancer growth and progression.

Dosage and Administration

The typical recommended dose for adults is 800 mg taken orally once daily. Votrient should be taken on an empty stomach, at least one hour before or two hours after a meal. Tablets should be swallowed whole and should not be crushed, chewed, or broken.

Patients with liver impairment may require dose adjustments based on their healthcare provider’s recommendations.

Common Side Effects

Common side effects associated with Votrient include:

• High blood pressure
• Diarrhea
• Nausea and vomiting
• Fatigue
• Loss of appetite
• Changes in hair color
• Headache
• Taste changes
• Weight loss
• Elevated liver enzymes

Not all patients experience these effects, and their severity may vary.

Important Safety Information

Votrient carries a warning for severe liver toxicity, which can occasionally be life-threatening. Regular liver function tests are required before and during treatment.

Patients should immediately report symptoms such as:

• Yellowing of the skin or eyes (jaundice)
• Dark urine
• Persistent nausea or vomiting
• Severe abdominal pain
• Unusual bruising or bleeding

Other serious risks may include heart rhythm abnormalities, hypertension, bleeding events, blood clots, and impaired wound healing.

Monitoring During Treatment

Healthcare providers typically monitor:

• Liver function
• Blood pressure
• Thyroid function
• Heart function (when appropriate)
• Blood counts and other laboratory parameters

Regular follow-up appointments help ensure safe and effective treatment.

Conclusion

Votrient (pazopanib) is an important targeted therapy for patients with advanced kidney cancer and certain soft tissue sarcomas. By blocking pathways that promote tumor growth and blood vessel development, it can help delay disease progression. Careful monitoring and adherence to medical guidance are essential to maximize benefits and manage potential side effects.